(Q50576208)

15 March 2018

review article

1 reference

title

[Sarcoidosis following pegylated interferon therapy: two cases]. (English)

1 reference

15 March 2018

1 reference

Souad Benali

1

1 reference

15 March 2018

Christian Boustière

2

1 reference

15 March 2018

Paul Castellani

3

1 reference

15 March 2018

Christine Cesari

4

1 reference

15 March 2018

Monique Jullien

5

1 reference

15 March 2018

Laurence Lecomte

6

1 reference

15 March 2018

Olivier Lebars

7

1 reference

15 March 2018

Gérard Lambot

8

1 reference

15 March 2018

Robert Loyer

9

1 reference

15 March 2018

Amina Masseboeuf

10

1 reference

15 March 2018

Hervé Perrier

11

1 reference

15 March 2018

Valérie Oules

12

1 reference

15 March 2018

Marc Bourlière

13

1 reference

15 March 2018

language of work or name

French

0 references

publication date

1 April 2006

1 reference

15 March 2018

Gastroenterologie Clinique et Biologique

published in

1 reference

15 March 2018

volume

30

1 reference

15 March 2018

issue

4

1 reference

15 March 2018

page(s)

615-619

1 reference

15 March 2018

cites work

Etiology of sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis after interferon therapy for chronic active hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

[Sarcoidosis in interferon-alpha therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis and IFN-alpha treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis induced by interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Interferon-induced sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis and interferon therapy: report of five cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

Sarcoidosis Following Combined Ribavirin and Interferon Therapy: a Case Report and Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973238-9

7 January 2021

10.1016/S0399-8320(06)73238-9

Identifiers

DOI

1 reference

15 March 2018

PubMed ID

16733389

1 reference

15 March 2018